Ocean Biomedical, Inc.

Ocean Biomedical, Inc. (Nasdaq: OCEA) is a clinical-stage biopharmaceutical company that completed its business combination with Aesther Healthcare Acquisition Corp., sponsored by Aesther Healthcare Sponsor LLC, and began trading as a public company in early 2023. Aesther Healthcare priced its SPAC IPO in 2021, targeting the healthcare and life sciences sector. Ocean Biomedical is focused on developing therapies across oncology, infectious disease, and pulmonary fibrosis, drawing from a pipeline rooted in research conducted at Brown University. The company filed an 8-K with the SEC on September 6, 2023, reflecting ongoing post-merger reporting obligations. For full filings, deal history, and analytics on Ocean Biomedical and thousands of other SPAC transactions, sign up for SpacDesk.